139 filings
Page 4 of 7
8-K
mgt6v l67qtjwuko
21 Jun 23
Virpax Pharmaceuticals Announces CFO Transition
4:16pm
8-K
z77751 gdi42
7 Jun 23
Departure of Directors or Certain Officers
4:15pm
ARS
5bt8 vkj2s
7 Jun 23
Annual report to shareholders
4:11pm
8-K
89pg2j5ni48 x1smfos3
12 May 23
Virpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments
4:10pm
8-K
erfp5omp1sax86snkwo
14 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
9pc05s10
28 Mar 23
Virpax Pharmaceuticals Announces Appointment of
4:05pm
8-K
nnk 8etm7u
22 Mar 23
Virpax Pharmaceuticals Reports 2022 Year-End Results
9:00am
8-K
4k7x1 aco
13 Mar 23
Regulation FD Disclosure
9:11am
8-K
0aqx0e
17 Feb 23
Other Events
9:02am
8-K
hlpypcord9scz2y
29 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
S-8
n06lt0eso6
22 Nov 22
Registration of securities for employees
4:06pm
8-K
p7drb19zm uo9
9 Nov 22
Virpax Pharmaceuticals Reports 2022 Third Quarter Results
9:05am
EFFECT
dlgtlx
19 Oct 22
Notice of effectiveness
12:15am
CORRESP
edokcq8h3nq8
14 Oct 22
Correspondence with SEC
12:00am
UPLOAD
ljyl oz7e
13 Oct 22
Letter from SEC
12:00am
S-3
9vx3 mhn9wf
7 Oct 22
Shelf registration
5:01pm